Lv2
180 积分 2025-02-13 加入
学海无涯
A phase II trial comparing dalpiciclib in combination with letrozole versus standard chemotherapy as neoadjuvant therapy in patients with high-risk HR- positive HER-2 negative breast cancer: DARLING-02
6个月前
已关闭
Breast cancer organoids derived from patients: A platform for tailored drug screening
6个月前
已完结
Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment
6个月前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
6个月前
已完结
皖公网安备34019202002308
